Categories
News

Veterinary Drugs Market 2020 Global Share, Future Growth, Demand and Forecasts to 2026

The rising demand for advanced drugs is likely to create lucrative growth opportunities for the Global Market, finds Fortune Business Insights in their new study. The study is titled “Veterinary Drugs Market” Analysis, Insights, and Forecasts, 2018 – 2025.” According to the study, the Global Veterinary Drugs Market will reach a valuation of US$ 27,570 Mn by 2025 from US$ 17,870.6 Mn in 2017, and exhibit a promising CAGR of 5.6% over the aforementioned forecast period.

The report covers:

  • Global Veterinary Drugs Market trends, with detailed analysis on consumer trends & manufacturer trends.
  • Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
  • Key areas of investments identifying market opportunities and challenges in forecast timeframe.
  • Competitive analysis of the industry players along with the overview on strategic management.
  • Comprehensive company profiles of the major industry players.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/veterinary-drugs-market-100171

Leading Players operating in the Veterinary Drugs Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

  • Zoetis
  • Intervet Inc.
  • Boehringer Ingelheim
  • Ceva
  • Elanco
  • Vetoquinol S.A.
  • Bayer AG
  • Other players

The Asia Pacific to Exhibit Fastest Growth Rate

The Global Veterinary Drugs Market rate of animal adoption is more in North America as compared to other regions. This, coupled with, the introduction of new animal-related products in the region will help it emerge dominant at a global scale. In 2017, North America held the highest share in the global veterinary drugs market and was valued at US$ 6290.1 Mn. It is also expected to continue dominating the market through the forecast period.

View For More [email protected] https://www.globenewswire.com/news-release/2019/06/19/1871258/0/en/Veterinary-Drugs-Market-to-reach-US-27-570-0-Mn-by-2025-at-a-CAGR-of-5-6-Exclusive-Report-by-Fortune-Business-Insights.html

On the other side, Asia Pacific is expected to show a remarkable growth rate in the coming years. The stringent rules imposed on animal healthcare by governments of nations in this region, coupled with, the involvement of animals in agricultural activities are propelling the veterinary drugs market in the Asia Pacific.

Global Veterinary Drugs Market Segmentation

By Product

  • Anti-infectives
  • Anti-inflammatory
  • Parasiticides
  • Others

By Animal

  • Companion
  • Livestock

By Route of Administration

  • Oral
  • Parenteral
  • Topical

Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Rise in Intake of Meat Consumption to Propel Market

The rise in the prevalence of infectious diseases among animals is driving the demand for veterinary drugs. Increasing poultry farming will bode well for the veterinary drugs market as well. Besides this, the market is likely to witness an increasing demand from pet farm owners. Introduction of cost-effective and advanced drugs will also help the market generate more revenue.

On the flipside, the discovery of new and complex diseases occurring in animals might increase the chances of contracting animal diseases such as bird flu, rabies, African swine flu, and others. Be it as it may, the rising incidence of these diseases are fueling the demand for more effective medicines and vaccines for animals. This might cause concern among animal owners and further propel the market for veterinary drugs.

Detailed Table of Content:

  1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

  1. Key Insights

4.1 Pipeline Analysis of Veterinary Drugs

4.2 Overview of Company Share Analysis

4.3 Overview of Strategies by Key Market Leaders

4.4 Key Industry Developments such as Mergers & Acquisitions

4.5 New Product Launches

4.6 Regulatory Scenario

4.7 Overview of Cost Analysis

  1. Global Veterinary Drugs Market Analysis, Insights and Forecast, 2014-2025

5.1. Key Findings / Summary

5.2. Market Analysis, Insights and Forecast – By Product

5.2.1 Anti-infectives

5.2.2 Anti-inflammatory

5.2.3 Parasiticides

5.2.4 Others

5.3. Market Analysis, Insights and Forecast – By Animal

5.3.1 Companion

5.3.2 Livestock

5.4 Market Analysis, Insights and Forecast – By Route of Administration

5.4.1 Oral

5.4.2 Parenteral

5.4.3 Topical

5.5. Market Analysis, Insights and Forecast – By Distribution Channel

5.5.1 Veterinary Hospitals

5.5.2 Veterinary Clinics

5.5.3 Pharmacies & Drug Stores

5.5.4 Others

5.6. Market Analysis, Insights and Forecast – By Region

5.6.1 North America

5.6.2 Europe

5.6.3 Asia Pacific

5.6.4 Latin America

5.6.5 Middle East & Africa

  1. North America Veterinary Drugs Market Analysis, Insights and Forecast, 2014-2025

6.1. Key Findings / Summary

6.2. Market Analysis – By Product

6.2.1 Anti-infectives

6.2.2 Anti-inflammatory

6.2.3 Parasiticides

6.2.4 Others

6.3. Market Analysis – By Animal

6.3.1 Companion

6.3.2 Livestock

6.4. Market Analysis – By Route of Administration

6.4.1 Oral

6.4.2 Parenteral

6.4.3 Topical

6.5. Market Analysis – By Distribution Channel

6.5.1 Veterinary Hospitals

6.5.2 Veterinary Clinics

6.5.3 Pharmacies & Drug Stores

6.5.4 Others

6.6. Market Analysis – By Country

6.6.1 U.S.

6.6.2 Canada

Continued…

Report Focus:

  • Extensive product offerings
  • Customer research services
  • Robust research methodology
  • Comprehensive reports
  • Latest technological developments
  • Value chain analysis
  • Potential Veterinary Drugs Market opportunities
  • Growth dynamics
  • Quality assurance
  • Post-sales support
  • Regular report updates

Reasons to Purchase this Report:

  • Comprehensive analysis of the Veterinary Drugs Market growth drivers, obstacles, opportunities, and other related challenges.
  • Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
  • Identifies market restraints and boosters.
  • Identifies all the possible segments present in the market to aid organizations in strategic business planning.

Related Reports:

Women’s Health Technology Market 2020 Global Top Leading Players, Industry Updates, Growth and Future Investments by Forecast to 2026

Monensin Market 2020 Global Industry Outlook, Trends, Size, Future Growth, Share, Regional Analysis by Key Players Forecast to 2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:[email protected]

Linkedin | Twitter | BLogs

Categories
Press Release

Veterinary Drugs Market 2019 Global Industry Share, Size, Top Leading Players, Emerging Trends, Region by Forecast to 2025

The rising demand for advanced drugs is likely to create lucrative growth opportunities for the Global Market, finds Fortune Business Insights in their new study. The study is titled “Veterinary Drugs Market Analysis, Insights, and Forecasts, 2018 – 2025.” According to the study, the Global Veterinary Drugs Market will reach a valuation of US$ 27,570 Mn by 2025 from US$ 17,870.6 Mn in 2017, and exhibit a promising CAGR of 5.6% over the aforementioned forecast period.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/veterinary-drugs-market-100171

The parasiticides segment accounted for the highest share in 2017 with market revenue of 32.2% and is likely to dominate the market in terms of product segmentation. This is because prevention of animals from insects and parasites is extremely important, in order to avoid its devastating impact on the animals and further on humans consuming products derived from such animals such as milk, eggs, and meat.

Segmentation:

Veterinary Drugs Market
Veterinary Drugs Market

By Animal

  • Companion
  • Livestock

By Product

  • Anti-infectives
  • Anti-inflammatory
  • Parasiticides

Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores

By Route of Administration

  • Oral
  • Parenteral
  • Topical

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/veterinary-drugs-market-100171

Rise in Intake of Meat Consumption to Propel Market

The rise in the prevalence of infectious diseases among animals is driving the demand for veterinary drugs. Increasing poultry farming will bode well for the veterinary drugs market as well. Besides this, the market is likely to witness an increasing demand from pet farm owners. Introduction of cost-effective and advanced drugs will also help the market generate more revenue.

On the flipside, the discovery of new and complex diseases occurring in animals might increase the chances of contracting animal diseases such as bird flu, rabies, African swine flu, and others. Be it as it may, the rising incidence of these diseases are fueling the demand for more effective medicines and vaccines for animals. This might cause concern among animal owners and further propel the market for veterinary drugs.

The Asia Pacific to Exhibit Fastest Growth Rate

The Global Veterinary Drugs Market rate of animal adoption is more in North America as compared to other regions. This, coupled with, the introduction of new animal-related products in the region will help it emerge dominant at a global scale. In 2017, North America held the highest share in the global veterinary drugs market and was valued at US$ 6290.1 Mn. It is also expected to continue dominating the market through the forecast period.

On the other side, Asia Pacific is expected to show a remarkable growth rate in the coming years. The stringent rules imposed on animal healthcare by governments of nations in this region, coupled with, the involvement of animals in agricultural activities are propelling the veterinary drugs market in the Asia Pacific.

Categories
Press Release

Veterinary Drugs Market: 2019 Market Share, Key Players and Competitive Landscape

According to the study, the Global Veterinary Drugs Market will reach a valuation of US$ 27,570 Mn by 2025 from US$ 17,870.6 Mn in 2017, and exhibit a promising CAGR of 5.6% over the aforementioned forecast period.

Some of the Main Key Players Covered in the Report: 

  • Zoetis
  • Intervet Inc.
  • Boehringer Ingelheim
  • Ceva
  • Elanco
  • Vetoquinol S.A.
  • Bayer AG
  • Other players

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/veterinary-drugs-market-100171

Major Table of Content for Veterinary Drugs Market: 

  1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

  1. Key Insights

4.1 Pipeline Analysis of Veterinary Drugs

4.2 Overview of Company Share Analysis

4.3 Overview of Strategies by Key Market Leaders

4.4 Key Industry Developments such as Mergers & Acquisitions

4.5 New Product Launches

4.6 Regulatory Scenario

4.7 Overview of Cost Analysis

  1. Global Veterinary Drugs Market Analysis, Insights and Forecast, 2014-2025

5.1. Key Findings / Summary

5.2. Market Analysis, Insights and Forecast – By Product

5.2.1 Anti-infectives

5.2.2 Anti-inflammatory

5.2.3 Parasiticides

5.2.4 Others

5.3. Market Analysis, Insights and Forecast – By Animal

5.3.1 Companion

5.3.2 Livestock

5.4 Market Analysis, Insights and Forecast – By Route of Administration

5.4.1 Oral

5.4.2 Parenteral

5.4.3 Topical

5.5. Market Analysis, Insights and Forecast – By Distribution Channel

5.5.1 Veterinary Hospitals

5.5.2 Veterinary Clinics

5.5.3 Pharmacies & Drug Stores

5.5.4 Others

5.6. Market Analysis, Insights and Forecast – By Region

5.6.1 North America

5.6.2 Europe

5.6.3 Asia Pacific

5.6.4 Latin America

5.6.5 Middle East & Africa

  1. North America Veterinary Drugs Market Analysis, Insights and Forecast, 2014-2025

6.1. Key Findings / Summary

6.2. Market Analysis – By Product

6.2.1 Anti-infectives

6.2.2 Anti-inflammatory

6.2.3 Parasiticides

6.2.4 Others

6.3. Market Analysis – By Animal

6.3.1 Companion

6.3.2 Livestock

6.4. Market Analysis – By Route of Administration

6.4.1 Oral

6.4.2 Parenteral

6.4.3 Topical

6.5. Market Analysis – By Distribution Channel

6.5.1 Veterinary Hospitals

6.5.2 Veterinary Clinics

6.5.3 Pharmacies & Drug Stores

6.5.4 Others

6.6. Market Analysis – By Country

6.6.1 U.S.

6.6.2 Canada

Continued…

The Asia Pacific to Exhibit Fastest Growth Rate

The Global Veterinary Drugs Market rate of animal adoption is more in North America as compared to other regions. This, coupled with, the introduction of new animal-related products in the region will help it emerge dominant at a global scale. In 2017, North America held the highest share in the global veterinary drugs market and was valued at US$ 6290.1 Mn. It is also expected to continue dominating the market through the forecast period.

On the other side, Asia Pacific is expected to show a remarkable growth rate in the coming years. The stringent rules imposed on animal healthcare by governments of nations in this region, coupled with, the involvement of animals in agricultural activities are propelling the veterinary drugs market in the Asia Pacific.

More Trending Topics From Fortune Business [email protected]

Mass Spectrometer Market Revenue to cross US$ 10,044.7 Mn| 2019 Worldwide Opportunities, Market Share, Key Players

Psoriatic Arthritis Treatment Market Size Worth US$ 12,175.2 Mn by 2026, says Fortune Business Insights

Categories
Press Release

Veterinary Drugs Market Growth, Size, Future Demands by Regional Forecast to 2025

The rising demand for advanced drugs is likely to create lucrative growth opportunities for the Global Veterinary Drugs Market, finds Fortune Business Insights in their new study. The study is titled “Veterinary Drugs Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025.” According to the study, the Global Veterinary Drugs Market will reach a valuation of US$ 27,570 Mn by 2025 from US$ 17,870.6 Mn in 2017, and exhibit a promising CAGR of 5.6% over the aforementioned forecast period.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/veterinary-drugs-market-100171

Major Table of Content for Veterinary Drugs Market: 

  1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

  1. Key Insights

4.1 Pipeline Analysis of Veterinary Drugs

4.2 Overview of Company Share Analysis

4.3 Overview of Strategies by Key Market Leaders

4.4 Key Industry Developments such as Mergers & Acquisitions

4.5 New Product Launches

4.6 Regulatory Scenario

4.7 Overview of Cost Analysis

Some of the Main Key Players Covered in the Report: 

  • Zoetis
  • Intervet Inc.
  • Boehringer Ingelheim
  • Ceva
  • Elanco
  • Vetoquinol S.A.
  • Bayer AG
  • Other players

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/veterinary-drugs-market-100171

Segmentation:

By Animal

  • Companion
  • Livestock

By Product

  • Anti-infectives
  • Anti-inflammatory
  • Parasiticides

Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores

By Route of Administration

  • Oral
  • Parenteral
  • Topical

The Asia Pacific to Exhibit Fastest Growth Rate

The Global Veterinary Drugs Market rate of animal adoption is more in North America as compared to other regions. This, coupled with, the introduction of new animal-related products in the region will help it emerge dominant at a global scale. In 2017, North America held the highest share in the global veterinary drugs market and was valued at US$ 6290.1 Mn. It is also expected to continue dominating the market through the forecast period.

More Trending Topics From Fortune Business [email protected]

Crop Protection Chemicals Market 2019 Global Size, Growth Insight, Regional, Share, Trends, Industry Key Players, Forecast to 2025

Medical Devices Market 2019 Global Industry Share, Size, Revenue, Business Boosting Strategies, CAGR Status, and Forecast 2025

Peritoneal Dialysis Market 2019 Global Industry Share, Top Players, Industry Size, Future Growth by 2025: Fortune Business Insights

Categories
Press Release

Veterinary Drugs Market: Opportunity, Growth Analysis says Fortune Business Insights

Veterinary Drugs Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025. According to the study, the Global Veterinary Drugs Market will reach a valuation of US$ 27,570 Mn by 2025 from US$ 17,870.6 Mn in 2017, and exhibit a promising CAGR of 5.6% over the aforementioned forecast period.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/veterinary-drugs-market-100171

Segmentation:

By Animal

  • Companion
  • Livestock

By Product

  • Anti-infectives
  • Anti-inflammatory
  • Parasiticides

Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores

By Route of Administration

  • Oral
  • Parenteral
  • Topical

The parasiticides segment accounted for the highest share in 2017 with market revenue of 32.2% and is likely to dominate the market in terms of product segmentation. This is because prevention of animals from insects and parasites is extremely important, in order to avoid its devastating impact on the animals and further on humans consuming products derived from such animals such as milk, eggs, and meat.

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/veterinary-drugs-market-100171

Major Table of Content for Veterinary Drugs Market: 

  1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

  1. Executive Summary
  2. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

  1. Key Insights

4.1 Pipeline Analysis of Veterinary Drugs

4.2 Overview of Company Share Analysis

4.3 Overview of Strategies by Key Market Leaders

4.4 Key Industry Developments such as Mergers & Acquisitions

4.5 New Product Launches

4.6 Regulatory Scenario

4.7 Overview of Cost Analysis

Some of the Main Key Players Covered in the Report: 

  • Zoetis
  • Intervet Inc.
  • Boehringer Ingelheim
  • Ceva
  • Elanco
  • Vetoquinol S.A.
  • Bayer AG
  • Other players

The Asia Pacific to Exhibit Fastest Growth Rate

The Global Veterinary Drugs Market rate of animal adoption is more in North America as compared to other regions. This, coupled with, the introduction of new animal-related products in the region will help it emerge dominant at a global scale. In 2017, North America held the highest share in the global veterinary drugs market and was valued at US$ 6290.1 Mn. It is also expected to continue dominating the market through the forecast period.

On the other side, Asia Pacific is expected to show a remarkable growth rate in the coming years. The stringent rules imposed on animal healthcare by governments of nations in this region, coupled with, the involvement of animals in agricultural activities are propelling the veterinary drugs market in the Asia Pacific.

More Trending Topics From Fortune Business [email protected]

Contraceptives Market to reach US$ 31,666.9 Mn by 2025, Recent Approvals from Medicines and Healthcare Regulatory Agency (MHRA) to Impel Growth, says Fortune Business Insights

Digital Blood Pressure Monitor Market to Exhibit 10.1% CAGR, Omron to Leading the Market with its Large Distribution Network, says Fortune Business Insights

Biopesticides Market to reach US$ 10.19 Billion by 2025, at a CAGR of 14.93% | Exclusive Report by Fortune Business Insights

Rise in Intake of Meat Consumption to Propel Market

The rise in the prevalence of infectious diseases among animals is driving the demand for veterinary drugs. Increasing poultry farming will bode well for the veterinary drugs market as well. Besides this, the market is likely to witness an increasing demand from pet farm owners. Introduction of cost-effective and advanced drugs will also help the market generate more revenue.

On the flipside, the discovery of new and complex diseases occurring in animals might increase the chances of contracting animal diseases such as bird flu, rabies, African swine flu, and others. Be it as it may, the rising incidence of these diseases are fueling the demand for more effective medicines and vaccines for animals. This might cause concern among animal owners and further propel the market for veterinary drugs.

About Us

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Categories
Press Release

Veterinary Drugs Market 2019 Industry Size by Global Major Companies Profile, Competitive Landscape and Key Regions 2025

The rising demand for advanced drugs is likely to create lucrative growth opportunities for the global veterinary drugs market, finds Fortune Business Insights in their new study. The study is titled “Veterinary Drugs Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025.” According to the study, the global veterinary drugs market will reach a valuation of US$ 27,570 Mn by 2025 from US$ 17,870.6 Mn in 2017, and exhibit a promising CAGR of 5.6% over the aforementioned forecast period.

Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/sample/veterinary-drugs-market-100171

The parasiticides segment accounted for the highest share in 2017 with market revenue of 32.2% and is likely to dominate the market in terms of product segmentation. This is because prevention of animals from insects and parasites is extremely important, in order to avoid its devastating impact on the animals and further on humans consuming products derived from such animals such as milk, eggs, and meat.

Rise in Intake of Meat Consumption to Propel Market

The rise in the prevalence of infectious diseases among animals is driving the demand for veterinary drugs. Increasing poultry farming will bode well for the veterinary drugs market as well. Besides this, the market is likely to witness an increasing demand from pet farm owners. Introduction of cost-effective and advanced drugs will also help the market generate more revenue.

On the flipside, the discovery of new and complex diseases occurring in animals might increase the chances of contracting animal diseases such as bird flu, rabies, African swine flu, and others. Be it as it may, the rising incidence of these diseases are fueling the demand for more effective medicines and vaccines for animals. This might cause concern among animal owners and further propel the market for veterinary drugs.

Nevertheless, the rising number of meat consuming people and increasing demand for animal products such as milk, ghee, cheese, and eggs are creating better growth opportunities for the veterinary drugs market. Governments are also imposing stringent regulatory measures for improving animal safety. Such policies will not only keep animals safe from diseases but also improve the quality of products we derive from them.

The Asia Pacific to Exhibit Fastest Growth Rate

The rate of animal adoption is more in North America as compared to other regions. This, coupled with, the introduction of new animal-related products in the region will help it emerge dominant at a global scale. In 2017, North America held the highest share in the global veterinary drugs market and was valued at US$ 6290.1 Mn. It is also expected to continue dominating the market through the forecast period.

On the other side, Asia Pacific is expected to show a remarkable growth rate in the coming years. The stringent rules imposed on animal healthcare by governments of nations in this region, coupled with, the involvement of animals in agricultural activities are propelling the veterinary drugs market in the Asia Pacific.

Vendors are entering into strategic collaborations, merger, and acquisitions, and new product launches in order to gain a strong foothold in the market. They are also investing huge sums into research and development strategies for the discovery of new drugs to prevent various diseases from occurring in animals.

Request Customization of this [email protected] https://www.fortunebusinessinsights.com/enquiry/customization/veterinary-drugs-market-100171

Zoetis to dominate the veterinary drugs market in terms of revenue

Zoetis emerged as the leading player with the highest market share in 2017, as the company has a significant and considerable market presence, a diverse portfolio of product offerings and an acute strategic perspective which includes mergers and acquisitions such as the 2018 acquisition of Abaxis. Other examples of strategic acquisitions of the company include Nexvet and Scandinavian Micro Biodevices. In addition, Zoetis is continuously involved in a variety of R&D initiatives such as animal cancer therapeutics. Other players operating in the veterinary drugs market are Intervet Inc., Boehringer Ingelheim International GmbH, Ceva, Elanco, Vetoquinol S.A., Bayer AG, etc.

4. Key Insights

4.1 Pipeline Analysis of Veterinary Drugs
4.2 Overview of Company Share Analysis
4.3 Overview of Strategies by Key Market Leaders
4.4 Key Industry Developments such as Mergers & Acquisitions
4.5 New Product Launches
4.6 Regulatory Scenario
4.7 Overview of Cost Analysis

Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

Browse Full [email protected] https://www.fortunebusinessinsights.com/industry-reports/veterinary-drugs-market-100171

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]

E-pharmacy Market 2019-2025: Global Size, Share, Emerging Trends, Demand, Revenue and Forecasts Research

At 9.1% CAGR, Prothrombin Complex Concentrate Market size to reach 1,076.5 Mn by 2025

Categories
Press Release

Veterinary Drugs Market to Exhibit 5.6% CAGR, Propel Growth, Develpoment, Trend, Forecast till 2025

The rising demand for advanced drugs is likely to create lucrative growth opportunities for the global veterinary drugs market, finds Fortune Business Insights in their new study. The study is titled “Veterinary Drugs Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025.” According to the study, the global veterinary drugs market will reach a valuation of US$ 27,570 Mn by 2025 from US$ 17,870.6 Mn in 2017, and exhibit a promising CAGR of 5.6% over the aforementioned forecast period.

The parasiticides segment accounted for the highest share in 2017 with market revenue of 32.2% and is likely to dominate the market in terms of product segmentation. This is because prevention of animals from insects and parasites is extremely important, in order to avoid its devastating impact on the animals and further on humans consuming products derived from such animals such as milk, eggs, and meat.

Request Sample PDF:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/veterinary-drugs-market-100171

Some of the Main Key Players Covered in the Report:

  • Zoetis
  • Intervet Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva
  • Elanco
  • Vetoquinol S.A.
  • Bayer AG
  • Other players

Rise in Intake of Meat Consumption to Propel Market

The rise in the prevalence of infectious diseases among animals is driving the demand for veterinary drugs. Increasing poultry farming will bode well for the veterinary drugs market as well. Besides this, the market is likely to witness an increasing demand from pet farm owners. Introduction of cost-effective and advanced drugs will also help the market generate more revenue.

On the flipside, the discovery of new and complex diseases occurring in animals might increase the chances of contracting animal diseases such as bird flu, rabies, African swine flu, and others. Be it as it may, the rising incidence of these diseases are fueling the demand for more effective medicines and vaccines for animals. This might cause concern among animal owners and further propel the market for veterinary drugs.

Nevertheless, the rising number of meat consuming people and increasing demand for animal products such as milk, ghee, cheese, and eggs are creating better growth opportunities for the veterinary drugs market.

Governments are also imposing stringent regulatory measures for improving animal safety. Such policies will not only keep animals safe from diseases but also improve the quality of products we derive from them.

Browse Complete Report Details:

https://www.fortunebusinessinsights.com/industry-reports/veterinary-drugs-market-100171

The Asia Pacific to Exhibit Fastest Growth Rate

The rate of animal adoption is more in North America as compared to other regions. This, coupled with, the introduction of new animal-related products in the region will help it emerge dominant at a global scale. In 2017, North America held the highest share in the global veterinary drugs market and was valued at US$ 6290.1 Mn. It is also expected to continue dominating the market through the forecast period.

On the other side, Asia Pacific is expected to show a remarkable growth rate in the coming years. The stringent rules imposed on animal healthcare by governments of nations in this region, coupled with, the involvement of animals in agricultural activities are propelling the veterinary drugs market in the Asia Pacific.

Vendors are entering into strategic collaborations, merger, and acquisitions, and new product launches in order to gain a strong foothold in the market. They are also investing huge sums into research and development strategies for the discovery of new drugs to prevent various diseases from occurring in animals. Some of the players operating in the veterinary drugs market are Bayer AG., Zoetis Animal Healthcare, Virbac S.A. Vetoquinol, Ceva, Vetoquinol S.A., Merial Animal Health, Merck Ltd., Elanco, Intervet Inc., and Boehringer Ingelheim International GmbH.

Major Table of Content for Veterinary Drugs Market:

 1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumption

2.Executive Summary

3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4. Key Insights

4.1 Pipeline Analysis of Veterinary Drugs

4.2 Overview of Company Share Analysis

4.3 Overview of Strategies by Key Market Leaders

4.4 Key Industry Developments such as Mergers & Acquisitions

4.5 New Product Launches

4.6 Regulatory Scenario

4.7 Overview of Cost Analysis

View More Related Reports:

Breast Cancer Therapeutics Market Worth US$ 38,573.5 Mn by Top International Players AstraZeneca, Pfizer Inc., Sanofi and more